Organ-on-chip Technology: Opportunities and Challenges

Overview

Journal Biotechnol Notes

Date 2024 Oct 17

PMID 39416695

Authors

Santosh Kumar Srivastava

Guo Wei Foo

Nikhil Aggarwal

Matthew Wook Chang

Affiliations

Soon will be listed here.

Abstract

Organ-on-chip (OOC) technology is an innovative approach that reproduces human organ structures and functions on microfluidic platforms, offering detailed insights into intricate physiological processes. This technology provides unique advantages over conventional in vitro and in vivo models and thus has the potential to become the new standard for biomedical research and drug screening. In this mini-review, we compare OOCs with conventional models, highlighting their differences, and present several applications of OOCs in biomedical research. Additionally, we highlight advancements in OOC technology, particularly in developing multiorgan systems, and discuss the challenges and future directions of this field.

Citing Articles

Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S.

Smieszek S, Przychodzen B, Tyner C, Johnson C, Bai H, Kwon J Mol Ther Nucleic Acids. 2025; 36(1):102479.

PMID: 40060931 PMC: 11889396. DOI: 10.1016/j.omtn.2025.102479.

Evaluation of Drug Permeation Enhancement by Using In Vitro and Ex Vivo Models.

Steyn J, Haasbroek-Pheiffer A, Pheiffer W, Weyers M, van Niekerk S, Hamman J Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006008 PMC: 11859300. DOI: 10.3390/ph18020195.

Organ-on-a-Chip Models-New Possibilities in Experimental Science and Disease Modeling.

Wysoczanski B, Swiatek M, Wojcik-Gladysz A Biomolecules. 2025; 14(12.

PMID: 39766276 PMC: 11674024. DOI: 10.3390/biom14121569.

Bridging silicon and carbon worlds with digital twins and on-chip systems in drug discovery.

Akbarialiabad H, Seyyedi M, Paydar S, Habibzadeh A, Haghighi A, Kvedar J NPJ Syst Biol Appl. 2024; 10(1):150.

PMID: 39702292 PMC: 11659457. DOI: 10.1038/s41540-024-00476-9.

Tiny Organs, Big Impact: How Microfluidic Organ-on-Chip Technology Is Revolutionizing Mucosal Tissues and Vasculature.

Dasgupta I, Rangineni D, Abdelsaid H, Ma Y, Bhushan A Bioengineering (Basel). 2024; 11(5).

PMID: 38790343 PMC: 11117503. DOI: 10.3390/bioengineering11050476.

References

Novak R, Ingram M, Marquez S, Das D, Delahanty A, Herland A . Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020; 4(4):407-420. PMC: 8057865. DOI: 10.1038/s41551-019-0497-x. View

Griffith L, Swartz M . Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol. 2006; 7(3):211-24. DOI: 10.1038/nrm1858. View

Picollet-Dhahan N, Zuchowska A, Lemeunier I, Le Gac S . Multiorgan-on-a-Chip: A Systemic Approach To Model and Decipher Inter-Organ Communication. Trends Biotechnol. 2021; 39(8):788-810. DOI: 10.1016/j.tibtech.2020.11.014. View

Akhtar A . The flaws and human harms of animal experimentation. Camb Q Healthc Ethics. 2015; 24(4):407-19. PMC: 4594046. DOI: 10.1017/S0963180115000079. View

Kim H, Li H, Collins J, Ingber D . Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc Natl Acad Sci U S A. 2015; 113(1):E7-15. PMC: 4711860. DOI: 10.1073/pnas.1522193112. View

Bedard P, Gauvin S, Ferland K, Caneparo C, Pellerin E, Chabaud S . Innovative Human Three-Dimensional Tissue-Engineered Models as an Alternative to Animal Testing. Bioengineering (Basel). 2020; 7(3). PMC: 7552665. DOI: 10.3390/bioengineering7030115. View

Mak I, Evaniew N, Ghert M . Lost in translation: animal models and clinical trials in cancer treatment. Am J Transl Res. 2014; 6(2):114-8. PMC: 3902221. View

Thorsteinsdottir H, Quach U, Daar A, Singer P . Conclusions: promoting biotechnology innovation in developing countries. Nat Biotechnol. 2004; 22 Suppl:DC48-52. PMC: 7097523. DOI: 10.1038/nbt1204supp-DC48. View

Bein A, Kim S, Goyal G, Cao W, Fadel C, Naziripour A . Enteric Coronavirus Infection and Treatment Modeled With an Immunocompetent Human Intestine-On-A-Chip. Front Pharmacol. 2021; 12:718484. PMC: 8573067. DOI: 10.3389/fphar.2021.718484. View

10.

Wadman M . FDA no longer has to require animal testing for new drugs. Science. 2023; 379(6628):127-128. DOI: 10.1126/science.adg6276. View

11.

Henderson V, Kimmelman J, Fergusson D, Grimshaw J, Hackam D . Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments. PLoS Med. 2013; 10(7):e1001489. PMC: 3720257. DOI: 10.1371/journal.pmed.1001489. View

12.

Sung J, Wang Y, Sriram N, Jackson M, Long C, Hickman J . Recent Advances in Body-on-a-Chip Systems. Anal Chem. 2018; 91(1):330-351. PMC: 6687466. DOI: 10.1021/acs.analchem.8b05293. View

13.

Skardal A, Murphy S, Devarasetty M, Mead I, Kang H, Seol Y . Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform. Sci Rep. 2017; 7(1):8837. PMC: 5562747. DOI: 10.1038/s41598-017-08879-x. View

14.

Sun A, Hoffman T, Luu B, Ashammakhi N, Li S . Application of lung microphysiological systems to COVID-19 modeling and drug discovery: a review. Biodes Manuf. 2021; 4(4):757-775. PMC: 8213042. DOI: 10.1007/s42242-021-00136-5. View

15.

Nolan J, Pearce O, Screen H, Knight M, Verbruggen S . Organ-on-a-Chip and Microfluidic Platforms for Oncology in the UK. Cancers (Basel). 2023; 15(3). PMC: 9913518. DOI: 10.3390/cancers15030635. View

16.

Mastrangeli M, Millet S, Mummery C, Loskill P, Braeken D, Eberle W . Building blocks for a European Organ-on-Chip roadmap. ALTEX. 2019; 36(3):481-492. DOI: 10.14573/altex.1905221. View

17.

Wienkers L, Heath T . Predicting in vivo drug interactions from in vitro drug discovery data. Nat Rev Drug Discov. 2005; 4(10):825-33. DOI: 10.1038/nrd1851. View

18.

Si L, Bai H, Rodas M, Cao W, Oh C, Jiang A . A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics. Nat Biomed Eng. 2021; 5(8):815-829. PMC: 8387338. DOI: 10.1038/s41551-021-00718-9. View

19.

Ingber D . Human organs-on-chips for disease modelling, drug development and personalized medicine. Nat Rev Genet. 2022; 23(8):467-491. PMC: 8951665. DOI: 10.1038/s41576-022-00466-9. View

20.

Bhatia S, Ingber D . Microfluidic organs-on-chips. Nat Biotechnol. 2014; 32(8):760-72. DOI: 10.1038/nbt.2989. View